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In addition to naturally occurring regulatory T (nTreg) cells derived from the thymus,
functionally competent Treg cells can be induced in vitro from peripheral blood lympho-
cytes in response to TCR stimulation with cytokine costimulation. Using these artificial
stimulation conditions, both naı¨ve as well as memory CD4+ T cells can be converted into
induced Treg (iTreg) cells, but the cellular origin of such iTreg cells in vivo or in response
to more physiologic stimulation with pathogen-derived antigens is less clear. Here, we
demonstrate that a freeze/thaw lysate of Plasmodium falciparum schizont extract (PfSE)
can induce functionally competent Treg cells from peripheral lymphocytes in a time-
and dose-dependent manner without the addition of exogenous costimulatory factors.
The PfSE-mediated induction of Treg cells required the presence of nTreg cells in the
starting culture. Further experiments mixing either memory or naı¨ve T cells with anti-
gen presenting cells and CFSE-labeled Treg cells identified CD4+CD45RO+CD25− memory
T cells rather than Treg cells as the primary source of PfSE-induced Treg cells. Taken
together, these data suggest that in the presence of nTreg cells, PfSE induces memory
T cells to convert into iTreg cells that subsequently expand alongside PfSE-induced effec-
tor T cells.
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Introduction
Two distinct populations of regulatory T (Treg) cells have been
described: “natural” regulatory T (nTreg) cells that arise in the thy-
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mus and circulate in the blood [1], and “adaptive” or “induced”
regulatory T (iTreg) cells, arising in the periphery in response to a
specific antigen stimulus [2]. The expansion of the Treg-cell popu-
lation in the periphery during infection has been attributed to both
proliferation of nTreg cells and conversion of CD4+CD25− cells to
iTreg cells [3,4]. iTreg cells are thought to develop in periph-
eral lymphoid tissue in response to specific antigenic stimulation
through the T-cell receptor (TCR), costimulatory receptors, and
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cytokine stimulation [5]. For instance, anti-CD3/CD28 stimula-
tion or exposure to antigen via immature DCs [6–8] has led to
conversion of conventional T cells into iTreg cells, and culturing
peripheral murine CD4+CD25− T cells with a well-defined nonself
antigen in the presence of TGF-β induces functional
FOXP3+CD25+, antigen-specific Treg cells [4]. Although this ob-
servation has been confirmed for human cells [9,10], the in-
duction of iTreg cells by TGF-β in human cells remains con-
troversial and depends on the antigen dose and the route of
administration [11–14], suggesting that different mechanisms
of induction may be relevant in different situations. In addi-
tion to TGF-β, an important role for IL-2 has been demon-
strated for the induction of human iTreg cells [15]. Fur-
thermore, Zheng and colleagues [9] showed that the pres-
ence of thymus-derived nTreg cells can greatly enhance the
cytokine-mediated induction of iTreg cells from human na¨ıve
peripheral CD4+CD25− cells (Tnaive), and in mice, activated
nTreg cells were shown to confer infectious tolerance in a TGF-β-
dependent manner [16].
However, to date, in vitro studies on the induction of Treg
cells from CD4+CD25− T cells tended to employ nonphysiologi-
cal stimuli such as TCR ligation via anti-CD3 in the presence of
exogenously added recombinant cytokines. Using these condi-
tions, iTreg cells can be induced from both na¨ıve and memory
T (Tmem) cells [17], but it is not at all clear which of these two
T-cell populations is most relevant under physiologic conditions
when antigen is encountered in vivo. There are, however, intrigu-
ing data derived ex vivo using deuterium-labeled glucose that
suggest that Treg cells are renewed from a pool of Tmem cells
[18]. To further investigate the pathways of iTreg-cell induction
that are most relevant to the in vivo situation will require stud-
ies using genuine antigens rather than artificial TCR agonists and
costimulatory molecules.
First studied for their role in autoimmunity and
tumor immunology [1,19,20], it is now clear that
CD4+CD25+FOXP3+CD127lo/− Treg cells also play a role in
infectious diseases [3,21]. They are, for instance, induced
upon infection with malaria in several different murine models
(reviewed in [22,23]), and data from experimentally infected
humans indicate that Plasmodium falciparum infection induces
Treg cells in vivo and that this correlates with a transient increase
in TGF-β [24]. More recently, Scholzen et al. [30] have shown
that intact, P. falciparum-infected RBCs induce Treg cells from
proliferating CD4+ CD25− cells in an IL-2, IL-10, and TGF-β
dependent manner, which does not require contact with antigen
presenting cells (APCs). However, the source of the CD4+ CD25−
cells (i.e. na¨ıve or memory) was not determined.
Here, we present data confirming that Treg cells are
activated and induced in vitro in response to malaria antigen in
a time- and dose-dependent manner. These iTreg cells were func-
tional in suppressing proliferation of CD4+CD25− cells. Further-
more, iTreg cells were derived from Tmem cells and this process
required the presence of nTreg cells, leading us to hypothesize
that nTreg cells are able to convert Tmem cells into iTreg cells
that subsequently expand in parallel to effector T (Teff) cells.
Results
Treg cells are induced in vitro in response to PfSE
To investigate whether P. falciparum antigens can induce Treg
cells in vitro, peripheral blood mononuclear cells (PBMCs) from
five healthy malaria-na¨ıve donors, each assayed twice, were cul-
tured for 7 days with growth medium (GM), uninfected red blood
cells (uRBCs), or P. falciparum schizont extract (PfSE) and the per-
centage of CD4+ cells expressing a Treg-cell (FOXP3+CD127lo/−)
or Teff-cell phenotype (defined as CD4+CD25+FOXP3− cells) was
determined ex vivo, and on days 2, 3, 4, 5, 6, and 7 by flow cyto-
metry (Fig. 1A and B). Considering that suppressive capacity is
predominantly found in FOXP3hi-expressing CD4+CD127lo/− cells
[25], CD4+CD127lo/− cells were further subdivided into FOXP3hi
and FOXP3lo-expressing cells. Values were normalized setting
the percentage of cells determined ex vivo as the baseline value
of 1.
The percentage of Treg cells (both FOXP3hi and FOXP3lo)
among CD4+CD127lo/− T cells that were unstimulated (GM; data
not shown) or cultured with uRBCs (Fig. 1C and D) was sta-
ble throughout the 7 days of the experiment. In contrast, among
cells cultured with PfSE, the percentage of FOXP3hi Treg cells
increased steadily from day 4 (Fig. 1B and C) and was, on aver-
age, 2.4-fold higher on day 6 than on day 0. The percentage of
FOXP3loCD4+CD127lo/− T cells showed a slight, albeit nonsignif-
icant increase in response to PfSE stimulation. While we cannot
formally rule out the possibility that the increasing proportion of
Treg cells over time in PfSE-stimulated cultures is simply due to
death of non-Treg cells, we consider this to be unlikely, since the
proportion of Teff cells among CD4+ T cells did not drop signifi-
cantly, but showed a tendency to increase toward the end of the
culture period (Fig. 1E).
Treg cells are induced in a dose-dependent fashion
We hypothesized that, if the induction of Treg cells is driven by
P. falciparum antigen, Treg-cell frequencies might increase with
increasing antigen dose. Cells were cultured for 6 days with five
different concentrations of PfSE (103–107 parasites/mL), equiv-
alent to parasitaemia levels commonly encountered in acute dis-
ease, and the percentage of FOXP3hi and FOXP3lo CD4+CD127lo/–
cells and Teff cells was determined. GM and uRBCs (at equiv-
alent doses to PfSE) were used as controls (Fig. 2A). Data are
expressed as the ratio of cells in PfSE cultures/uRBC cultures.
The percentage of both, FOXP3hiCD4+CD127lo/– cells (Fig. 2B) as
well as the percentage of Teff cells (Fig. 2C) increased significantly
with increasing antigen concentration, resulting in a stable ratio of
Teff:FOXP3hiCD4+CD127lo/– cells (Fig. 2D), while the percentage
of FOXP3loCD4+CD127lo/– cells did not vary significantly. Taken
together, and in line with our observations made ex vivo [26],
this suggests that PfSE-induced upregulation of Teff is balanced
by a commensurate increase in iTreg cells, expressing high levels
of FOXP3. However, the ratio of Teff to FOXP3hi Treg cells did
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Figure 1. Treg cells are induced and activated by P. falciparum schizont extract (PfSE). PBMCs were cultured for up to 7 days with growth medium
(GM), uninfected red blood cells (uRBCs), or PfSE (PfSE, at a 2 parasite:1 PBMC ratio, equivalent to 2 × 106 parasites/mL). Cells were stained for
CD4, CD25, CD127, and FOXP3 and the percentage of FOXP3+CD127lo/− and CD25+FOXP3−CD4+ cells was determined ex vivo, and after 2, 3, 4, 5,
6, and 7 days of culture. (A) Lymphocytes were gated, followed by CD4+ cells. Treg cells were defined as CD4+FOXP3+CD127lo/− cells. In order to
draw this gate, cells were first gated on CD4+FOXP3+ cells, and the CD127lo/+ cutoff was determined on the CD4+FOXP3+ population, where two
populations are clearly visible. These gates were then applied to CD4+ T cells, displayed as FOXP3 versus CD127. On this plot, FOXP3+CD127lo/−
cells were further divided into FOXP3hi and FOXP3lo-expressing cells. T effector (Teff) cells were defined as CD4+CD25+FOXP3−. (B) Representative
stainings of PBMCs from one of five donors, treated and gated as in (A). The kinetics of (C) CD4+FOXP3hiCD127lo/−, (D) CD4+FOXP3loCD127lo/−Treg,
and (E) Teff cells (CD4+CD25+FOXP3−) in response to uRBCs and PfSE are shown. Expression levels on day 0 were set to “1”, and values measured
on subsequent days were expressed as a fold change compared to day 0. Data are based on the collection of 50,000 lymphocytes. Data are shown
as mean ± SEM of values from five donors (each tested twice in independent experiments). R values and p values are derived from regression
analysis.
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Figure 2. Treg cells are induced and activated by PfSE in a dose-dependent manner. PBMCs were cultured for 6 days with different concentrations
of PfSE (103, 104, 105, 106, 107 parasites/mL). Uninfected red blood cells were used as a control. On day 6, cells were stained for CD4, CD25,
CD127, and FOXP3. (A) Representative staining using the gating strategy defined in Fig. 1A. The level of (B) FOXP3hi (circles) and FOXP3lo (squares)
CD4+FOXP3+CD127lo/− cells, and (C) T effector cells (CD4+CD25+FOXP3−) is shown, expressed as the ratio of cellsmeasured in PfSE/uRBC stimulated
wells. In (D), the ratio of Teff:CD4+FOXP3hiCD127lo/− cells is shown. Data are based on the collection of 50,000 lymphocytes. Data are shown as
± SEM from five donors, each tested twice in independent experiments. R values and p values derived from regression analysis.
increase at the highest antigen concentration (107 parasites/mL),
suggesting that — as we have observed in children with acute
clinical malaria [27] — at higher concentrations of antigen, the
coregulation of Teff and Treg cells may fail.
PfSE-induced Treg cells are functionally suppressive
Since it has been shown that activated Teff can transiently up-
regulate FOXP3 in culture without acquiring suppressive function
[28], it is important to verify whether the PfSE-induced cells ex-
pressing a Treg cell phenotype were indeed functional Treg cells.
Following an approach described by Hisaeda [29], cells were cul-
tured for 6 days in GM, uRBCs, or PfSE. On day 6, CD25+ and
CD25− cells were purified using CD25 microbeads, recombined at
varying CD25+:CD25− ratios of 0:1, 1:20, 1:4, 1:1, cultured for
a further 3 days with anti-CD3/anti-CD28 antibodies, and their
proliferation analyzed by 3H-thymidine incorporation since only
approximately 25% (median 27.2%, IQR 11.1 – 37.5) of CD25+
selected cells actually express the CD127lo/− FOXP3+ phenotype,
the true ratio of Treg cells:non-Treg cells in these cultures was in
fact much lower (approximately 0:1, 1:76, 1:19, 1:7)).
Despite the modest purity of Treg cells achieved with this
isolation method, increasing the ratio of CD25+ to CD25− cells
significantly reduced the proliferative response to anti-CD3/anti-
CD28 in the GM (data not shown) or uRBC-stimulated cultures
(Fig. 3A). In the PfSE-stimulated cultures, this effect was even
more pronounced. The CD25+ cells isolated from PfSE-stimulated
cultures contained significantly more FOXP3hi cells than CD25+
cells isolated from uRBC-stimulated cultures (p = 0.004, Fig. 3B),
while the percentage of FOXP3lo cells was similar in CD25+ cells
isolated from both culture conditions (p = 0.57, Fig. 3C). Taken
together, this suggests that the preferential induction of FOXP3hi
cells in response to PfSE stimulation is responsible for the en-
hanced suppression caused by CD25+ cells isolated from PfSE-
stimulated cultures.
Induction of Treg cells by PfSE requires Treg cells in
the primary culture
It has been established previously that upregulation of Treg cells
in response to stimulation with intact infected red blood cells
(iRBCs) requires activated monocytes, as well as IL-2, IL-10, and
TGF-β [30]. In these experiments, Treg cells were predominantly
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Figure 3. Induced Treg cells suppress proliferation. PBMCs were cultured for 6 days with GM, uRBCs, or PfSE. Cells were separated into
CD25+ and CD25− PBMCs using Miltenyi CD25 beads. CD25+ and CD25− were cultured in triplicate wells in 96 well plates in different
ratios (0:1, 1:20, 1:4, 1:1) and incubated with CD3/CD28. Cells were incubated for a further 18 h with 3H-thymidine before being ana-
lyzed in a scintillation counter. The proliferation was measured as counts per minute, and normalized on proliferation in wells contain-
ing CD25− cells only. (A) The median and interquartile range of values from five donors (each tested twice in independent experiments)
is shown. R values and p values derived from linear regression analysis (df = 18). The proportion of CD4+CD25+CD127lo/− cells among iso-
lated CD25+ cells expressing either (B) high or (C) low levels of FOXP3 is shown for uRBC- and PfSE-stimulated cultures. Box plots show
median and interquartile ranges with whiskers indicating the 5 and 95% percentiles from five donors, each tested twice in independent
experiments.
derived from CD25−FOXP3−CD4+ T cells, raising the intriguing
question whether memory or na¨ıve T cells can convert into Treg
cells as previously suggested [4,18], and whether the presence of
Treg cells is required to initiate this process. To further explore
the cellular requirements for PfSE-mediated Treg cell induction,
CD25+ cells were depleted from freshly isolated PBMCs that were
then cultured for 6 days with GM, uRBCs, or PfSE; mock-depleted
cells were used as a control.
In the mock-depleted samples, as expected, the proportion of
Treg cells among CD4+ cells increased significantly from day 0 to
day 6 in the PfSE-stimulated cultures and was significantly higher
than in the control cultures (Fig. 4). As demonstrated in Fig. 1,
this increase was predominantly driven by a 3.9-fold increase of
FOXP3hiCD4+CD127lo/− cells, compared to a 1.4-fold increase in
FOXP3lo-expressing cells. However, in the CD25-depleted PBMC
cultures, the proportion of Treg cells remained low throughout
the culture period and there was no significant change in the
proportion of Treg cells over time or between culture conditions.
We conclude, therefore, that the PfSE-mediated increase in Treg
cells is either due to proliferation of preexisting CD25+ nTreg
cells, or that conversion of CD25− cells into iTreg cells requires
the presence of CD25+ nTreg cells in the culture.
Memory T cells convert into Treg cells upon
stimulation with PfSE
To further investigate whether the increase in Treg cells seen in
response to PfSE stimulation was primarily due to proliferation of
preexisting Treg cells or to conversion of na¨ıve and/or Tmem cells
into FOXP3-expressing cells, we designed an experiment where
either Tmem or Tna¨ıve cells depleted of Treg cells were mixed
with CFSE-labeled Treg cells and stimulated for 5 days with uRBCs
or PfSE in the presence of APCs (see Supporting Information Fig. 1
for experimental design, and purities of cell subsets). Blood was
Figure 4. Depletion of nTreg cells abrogates the induction of Treg cells.
PBMCs were depleted of CD25+ cells using Miltenyi CD25 beads (deple-
tion of 96.41% [CI 95% 95.25–97.57], resulting in 75.78% (CI 95% 66.42–
85.13) Treg-cell depleted). CD25− PBMCs and mock-depleted PBMCs
were cultured for 6 days with GM, uRBCs, and PfSE. On day 6, cells were
stained with CD4, CD25, CD127, and FOXP3. (A) Representative staining
of CD25−-depleted (top panel) and mock-depleted (bottom panel) cells.
(B) After 6 days of culture, the percentage of CD4+FOXP3+CD127lo/− cells
was determined in the depleted (filled bars) and the mock-depleted
cells (open bars). The white area of the bar represents the proportion
of CD4+FOXP3loCD127lo/−cells, the striped area represents the propor-
tion of CD4+FOXP3hiCD127lo/-cells. Data are based on the collection of
50,000 lymphocytes. Data are shown as ± SEM from five donors, each
tested twice in independent experiments. p values calculated using the
Mann–Whitney test.
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Figure 5. PfSE stimulation induces iTreg cells from Tmem cells. The proportion of viable CD4+ T cells expressing a Treg-cell phenotype after
5 days culture is shown for PBMCs stimulated with (A) uRBCs, (B) PfSE, (C) anti-CD3, and TGFβ, for the cell mix containing “Tnaive” + “APC” +
“Treg”, stimulated with (D) uRBCs, (E) PfSE; for the cell mix containing “Tmem” + “APC” + “Treg,” stimulated with (F) uRBCs, (G)PfSE; and for
(H) CFSE-labeled “Treg” stimulated with SEB. (I–M) The histograms depict the proportion of CFSE+/− cells expressing a Treg-cell phenotype gated
in the corresponding graphs (D–H). A summary of the proportion of viable CD4+ T cells expressing a Treg-cell phenotype prior to and after culture
is shown for (N) PBMCs, (O) the cell mix containing “Tnaive” + “APC” + “Treg cells” and (P) “Tmem” + “APC” + “Treg cells.” (Q) The proportion of
CFSE-negative cells expressing a Treg-cell phenotype prior to and after culture is shown for the cell mixes containing either naı¨ve or Tmem cells.
Data are shown as mean ± SEM. Representative plots from one of three experiments are shown in A to H.
obtained from three adult donors who had a confirmed episode of
P. falciparum infection in the last 5 months.
PBMCs were incubated for 5 days with uRBCs (Fig. 5A), or
PfSE (Fig. 5B). In addition, PBMCs were stimulated with anti-
CD3 and TGF-β (Fig. 5C), and CFSE-labeled enriched “Treg” were
stimulated with staphylococcus enterotoxin B (SEB) (Fig. 5H).
Representative examples for the proportion of CD4+ T cells ex-
pressing a Treg-cell phenotype in the cell mix containing “Tnaive
+ APC + Treg” are depicted in Fig. 5D (uRBC stimulated) and
E (PfSE stimulated), and for the cell mix containing “Tmem
+ APC + Treg”, examples are shown in Fig. 5F (uRBC stimu-
lated) and G (PfSE stimulated). Stimulation with either PfSE or
TGF-β/anti-CD3 induced significant expansion of Treg cells in
PBMCs (Fig. 5N). While the proportion of CD4+ T cells express-
ing a Treg-cell phenotype in the “Tnaive mix” cultures did not
change during the culture period (Fig. 5O), the proportion of
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Treg cells in the “Tmem mix” almost doubled in response to
stimulation with PfSE, being significantly higher as compared
to both Treg cells in the “Tmem mix” on day 0 or after stimu-
lation with uRBCs (Fig. 5P). This indicates that PfSE-mediated
induction of Treg cells requires the presence of Tmem but not
Tna¨ıve cells. The histograms showing the proportion of Treg-cell
staining for CFSE in the various cell mixes (defined in Fig. 5D–
H) after the culture period are shown in Fig. 5I–M, and reveal
that proliferation of cells with a Treg-cell phenotype (as indi-
cated by sequential dilution of CFSE) was only observed for
SEB-stimulated preexisting “Treg” (Fig. 5M). However, the pro-
portion of cells expressing a Treg-cell phenotype that are CFSE
negative increased significantly in the PfSE-stimulated “Tmem
mix” (Fig. 5L) from a mean of 23.6% on day 0 to a mean of
68.3% on day 5 (Fig. 5Q). While it could be argued that stimu-
lation with PfSE resulted in extensive proliferation of Treg cells
(i.e. completely diluting out the CFSE), we consider this to be
highly unlikely—given that even stimulation of “Treg” with SEB
(Fig. 5M) did not result in complete dilution of CFSE. Taken
together, therefore, these data are compatible with the hypoth-
esis that PfSE-mediated induction of Treg cells is primarily due to
a conversion of Tmem cells into iTreg cells.
Discussion
The induction of Treg cells in response to TCR stimulation has been
studied in a variety of experimental models and diseases both in
mice and men, and a variety of mediators essential to this pro-
cess has been identified. However, the cellular origin of Treg cells
expanding in response to an antigenic stimulus is not entirely clear.
An obvious possibility is that Treg cells might regenerate contin-
uously from pre-existing Treg cells throughout life. Indeed, Treg
cells have now been shown to proliferate rapidly in humans in vivo
[31]. However, the observation that Treg cells are — in contrast
to Tmem cells — highly proapoptotic [26,32–34], would imply
that Treg cells must have an extraordinarily high regenerative po-
tential if this was their primary mechanism of maintenance over
the duration of a human life span. But, in fact, their capacity for
repeated self-regeneration is limited [18]: In contrast to
Tmem cells, Treg cells lack the ability to upregulate telom-
erase activity, which makes them prone to telomere erosion
[31,35]. An additional mechanism for Treg-cell expansion dur-
ing an immune response — other than exclusive prolifera-
tion of preexisting Treg cells — is thus likely. Several stud-
ies have demonstrated that Treg cells can be induced along-
side Teff cells from human CD4+ CD25− T cells in re-
sponse to stimulation with CD3/CD28 and the appropriate
cytokine cocktail [11], with some studies identifying the source as
either Tnaive cells [9], or both Tnaive and Tmem cells [17]. Stim-
ulation of CD4+CD25− T cells with intact P. falciparum-infected
RBCs led to induction of Treg cells [30], but this study did not
define the phenotype of the CD4+CD25− T cells giving rise to the
Treg cells.
The observation that Treg and Tmem cells display, on
average, 80% homology in their TCR Vβ usage [35–37] implies
close relatedness between these two cells and has prompted the
hypothesis that in vivo, a substantial proportion of Treg cells
induced in response to antigenic stimulation might be derived
from conversion of Tmem into Treg cells [18,31]. The data pre-
sented in here are among the first to demonstrate that Tmem
cells can indeed give rise to cells expressing a Treg-cell pheno-
type (CD4+CD127lo/−FOXP3+) in response to stimulation with a
clinically relevant antigen without exogenously added costimula-
tory factors, and further indicate that proliferation of preexisting
Treg cells makes little if any contribution to the antigen-induced
increase in Treg cells.
Nevertheless, we noticed that the PfSE-mediated induction of
Treg cells was dependent on the presence of Treg cells in the
starting culture. This is in agreement with the results of Scholzen
et al., who observed that intact P. falciparum-infected RBCs
induced substantially fewer Treg cells from CD25-depleted PBMCs
than from whole PBMCs [30]. Considering that these experi-
ments were carried out using blood from malaria-na¨ıve indi-
viduals, it can be assumed the Treg cells required to induce
this process are naturally occurring nTreg cells. In our mixing
experiments, CFSE-labeled Treg cells did not proliferate in re-
sponse to PfSE, confirming that proliferation of preexisting Treg
cells is not the primary explanation of the increase in Treg cells
in PfSE cultures and suggesting they may serve another func-
tion. Our data are reminiscent of “infectious tolerance” [38]
where nTreg cells were shown to confer suppressive activity onto
conventional CD4+ T cells that were subsequently shown to de-
velop a Treg cell phenotype including FOXP3 expression [39].
More recent studies have begun to unravel the molecular mech-
anism of infectious tolerance, and how the malaria parasite
might regulate this process. In mice, TGF-β bound to its latency-
associated peptide is present on activated nTreg cells. Once
converted into its bioactive from, membrane-bound TGF-β was
shown to exert a paracrine effect on neighboring T cells, in-
ducing them to become iTreg cells [16]. A recent elegant study
demonstrated that PfSE converted latent TGF-β bound to the
membrane of activated human Treg cells into its bioactive form,
resulting in the expansion of Treg cells [40]. Taken together,
it is tempting to speculate that malaria parasites might initi-
ate the induction of iTreg cells by activating membrane-bound
TGF-β on nTreg cells that exerts a paracrine effect on Tmem
cells, converting them into iTreg cells. Another avenue worth
exploring when studying the mechanism of infectious tolerance
is the role of IL-35, considering that Treg cells were shown re-
cently to confer suppressive activity to conventional T cells in an
IL-35 dependent manner [41].
Although several studies report a transient upregulation of
FOXP3 in activated human Teff CD4+ cells that is not associ-
ated with the acquisition of suppressive function [28,42,43], it
is highly unlikely that Teff activation explains our results. Firstly,
we established that the FOXP3+ cells induced by PfSE stimulation
are functionally competent and able, in a dose-dependent man-
ner, to suppress proliferation of Teff cells. Moreover, the transient
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Figure 6. Model for induction of Treg cells in response to antigenic
stimulation. In the appropriate cytokine environment, and upon pre-
sentation of their cognate antigen memory T (Tmem) cells convert into
(A) effector T (Teff) cells, or (B) induced Treg (iTreg) cells. The formation
of the latter requires contact of the Tmem cells with a preexisting Treg
cells (whichmay involvemembrane-bound TGF-β, activated by the par-
asite). Both Teff and iTreg cells subsequently proliferate in a balanced
manner.
FOXP3 expression described for human Teff cells peaked at day
3 and declined rapidly thereafter [42–44], while we performed
our analysis on cells cultured for at least 5 days. Most impor-
tantly, the transient increase of FOXP3 in these studies was not
associated with the acquisition of a Treg cell phenotype [44], and
FOXP3 expressing Teff cells maintained CD127 expression [42],
while we defined PfSE-induced Treg cells stringently as CD127lo/−-
expressing cells.
An intriguing question is how Tmem-derived Treg cells expand.
Do large fractions of Tmem cells simply convert into iTreg cells,
or do converted Treg cells subsequently expand by proliferation?
When whole PBMCs were labeled with CFSE and stimulated with
intact iRBCs, Scholzen et al. observed [30] an initial upregulation
of FOXP3 expression for the first 3 days in the absence of prolif-
eration that was then followed by proliferation of FOXP3+ cells.
In a variation of that approach, we directly labeled purified Treg
cells with PfSE prior to putting them into culture with unlabeled
Tmem cells. While we find no evidence for proliferation of the Treg
cells that were added initially, we do observe a population of non-
CFSE-labeled Treg cells emerging from the Tmem-cell population.
When interpreted together, these experiments suggest that upon
encounter with the antigen, some Tmem cells are converted into
iTreg cells and these iTreg cells subsequently expand by prolifer-
ation. As discussed above, the initiation of this process seems to
require the presence of CD25+ cells that could be nTreg cells (see
Fig. 6). While we and others [30] have demonstrated that Treg
cells generated by stimulation of PBMCs with malarial antigens
are suppressive, future experiments need to formally establish the
suppressive capacity of Treg cells derived from Tmem cells in
response to PfSE stimulation. In this respect, better strategies to
obtain highly purified CD4+CD127−/loFOXP3+ T cells would be
most desirable. While the approach based on CD25 chosen in this
study may be sufficient to deplete CD4+CD127−/loFOXP3+ T cells,
more sophisticated mechanistic studies on malaria-induced Treg
cells will require highly purified Treg populations that cannot be
achieved with the approach chosen here. Our data also suggest
that Teff and Treg cells increase in parallel in response to PfSE
stimulation in vitro. This is in line with the kinetics of Treg and
Teff cells we have described previously, ex vivo, for individuals
exposed to seasonal malaria [26], and consistent to a previous re-
port where a parallel increase in Treg and Teff cells was observed
for cells derived from a skin blister after intradermal injection of
purified protein derivative of tuberculin (PPD) to BCG-vaccinated
individuals [43]. These examples of a tightly regulated expan-
sion of Teff and Treg cells lend support to the hypothesis that in
response to an antigenic stimulus, Tmem clones give rise to both
Teff- and Treg-cell populations that subsequently expand [18],
most probably in response to the presence of cytokines such as
IL-2, in order to maintain immune homeostasis.
Materials and methods
Donors and preparation of cells
Donors were recruited from the expatriate work force at the Medi-
cal Research Council (MRC) Laboratories, The Gambia. All donors
were healthy, and unless indicated otherwise, malaria naive. Blood
was collected after written informed consent was obtained. Eth-
ical approval was given by the Gambian Government/MRC Joint
Ethics Committee and by the London School of Hygiene and Trop-
ical Medicine Ethics Committee, United Kingdom.
For the studies on malaria-na¨ıve individuals, up to 30 mL of
venous blood was collected into heparinized vacutainers (BD).
The blood was diluted in an equal volume of RPMI 1640, and
PBMCs were isolated by density centrifugation using Nycoprep
(Sigma-Aldrich). PBMCs were washed twice in RPMI 1640, and
resuspended at 106 cells/mL in GM (RPMI 1640, 10% AB+
serum (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich),
100 μg/mL streptomycin (Sigma-Aldrich), 2 mM L-glutamine (In-
vitrogen Life Technologies)). Cells were then immediately stained
for flow cytometry, or put into culture.
Cell surface and intracellular staining for flow
cytometry
Fresh or cultured cells were washed twice in FACS buffer (1×
PBS, 2mM EDTA, and 1% FBS (Invitrogen Life Technologies)),
and stained for surface markers at 4
◦
C in the dark for 30 min.
Intracellular staining was performed following the FOXP3 staining
protocol (Ebioscience). The following Abs were used: CD4 PerCP,
CD25 FITC, IgG1 PerCP, IgG1 FITC (all BD Biosystems), CD127
PE, FOXP3 allophycocyanin (clone PCH101), IgG1 PE, rat IgG2A
allophycocyanin (all from Ebioscience). Samples were acquired
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on a CyanTM ADP flow cytometer using Summit software (Dako).
Analysis was performed using FlowJo (Tree Star Inc.).
Cell separations
CD25 depletion was achieved using CD25 microbeads accord-
ing to the manufacturer’s instructions (Miltenyi Biotech, Ger-
many). Depletion removed on average 95% (95% CI: 93–97%)
of CD25+ cells, resulting in a depletion of 76% (95% CI: 66–
85%) of CD4+FOXP3+CD127−/lo cells. Cells were mock depleted
by adding cells to the matrix column without prior incubation with
CD25 microbeads. CD25+ cells were recovered from the column
according to the manufacturer’s instructions.
CD4+CD45RA+ na¨ıve T cells were isolated using the na¨ıve
T-cell isolation kit (Miltenyi Biotech) according to the manufac-
turer’s instructions. A purity of 68% (95% CI: 56–90%) was ob-
tained.
Preparation of malarial antigens
P. falciparum parasites of the clone 3D7 were grown following
the methods of Trager and Jensen [45] in O+ human erythrocytes
from healthy donors in RPMI (Invitrogen, Life Technologies), sup-
plemented with 25 mM HEPES (Sigma-Aldrich), 28 mM sodium
bicarbonate (BDH), 20 ug/L hypoxanthine (Sigma-Aldrich), 5%
albumax, and 5% human AB+ serum (Sigma). Cultures were
gassed with 3% O2, 4% CO2, and 93% N2, and incubated at 37◦C.
The culture medium was changed daily and the parasitaemia was
determined by examination of Giemsa-stained thin blood smears.
Mature schizonts were harvested from cultures of 5–8% para-
sitaemia by centrifugation through a Percoll/Sorbitol gradient
(Sigma-Aldrich, >95% purity). PfSE was prepared by two rapid
freeze-thaw cycles in liquid nitrogen and a 37◦C water bath. All
cultures were routinely shown to by Mycoplasma free by PCR (Bio
Whittaker).
Cell culture
Cells were cultured in 48 well plates for a maximum of 7 days.
PfSE was used at a concentration equivalent to two iRBCs per
mononuclear cell (PBMC). A similar freeze thaw preparation of
uRBCs was used as a control. GM was used as a negative con-
trol. For dose-dependence assays, PfSE was used in five different
concentrations (103, 104, 105, 106, 107 parasites per mL).
Treg-cell suppression assay
Cells were cultured in 24 well plates for 6 days with PfSE. uRBCs
and GM were used as negative controls. On day 6, CD25+ cells
were depleted from PBMCs using anti-CD25 mAb-conjugated mi-
crobeads as described above. The phenotype of cell fractions was
analyzed by flow cytometry as described above. CD25+ and CD25−
cells were cultured in triplicate wells in 96 well plates for 3 days
with soluble anti-CD3 and anti-CD28 at ratios of 0:1, 1:20, 1:4,
and 1:1 CD25+:CD25− cells.
On day 3, 1 μCi of 3H-thymidine (Amersham, UK) was added
to each well. Eighteen hours later, cells were harvested onto cel-
lulose filters, and tritium incorporation was measured by liquid
scintillation counting (MicroBeta Counter, PerkinElmer).
T-cell conversion assay
In a separate series of experiments, PBMCs from three expatriate
donors with a documented episode of malaria in the last 5 months
were used to address whether the increase in Treg cells seen
in response to PfSE stimulation was due to proliferation of
preexisting Treg cells or the induction of a Treg-cell phenotype in
Tmem cells (see Supporting Information Fig. 1A for experimental
setup). Using magnetically labeled beads from Miltenyi biotech
according to the manufacturer’s instructions, PBMCs were
depleted of CD45RA+ and CD25+ cells to obtain a population
enriched for Tmem cells and depleted of na¨ıve T cells and Treg
cells. Na¨ıve CD45RA+ T cells (Tnaive cells) were isolated from
PBMCs, previously depleted of CD25+ cells. APCs were prepared
by positive selection of HLADR+ cells from PBMCs that were
subsequently depleted of CD4+ cells to avoid contamination
with Treg cells and other CD4+ T cells. To enrich Treg cells,
CD25hi cells were positively selected from PBMCs. Treg cells were
subsequently labeled with 1 μM CFSE (Cell Trace, Invitrogen)
following a previously described protocol [46]. The purity of cell
fractions was determined by flow cytometry using the following
surface marker antibodies: anti-CD127 (PE), anti-CD45RA (Pe-
Cy7), anti-HLA-DR (allophycocyanin-EFluor, all Ebioscience),
anti-CD45RO (ECD, from Beckman Coulter), anti-CD4 (PerCP),
and anti-CD25 (allophycocyanin, both from BD Biosystems), and
the LIVE/DEAD fixable aqua dead cell stain kit from Invitrogen.
Intracellular staining for FOXP3 was performed according to the
Ebioscience protocol using anti-FOXP3 (Efluor 450). Appropriate
isotype controls were used, and samples were acquired and ana-
lyzed as described above. Subsequently, 960,000 Tmem or Tnaive
cells were mixed with 100,000 APC and 40,000 CFSE-labeled
Treg cells. The mix was analyzed by flow cytometry to determine
the proportion of CFSE-labeled Treg cells, using the panels
described above. Untouched PBMCs and the cell mixtures were
incubated for 5 days at 37
◦
C and 5% CO2 with PfSE or uRBCs at
a concentration equivalent to a ratio of five RBCs per one PBMC.
In addition, PBMCs were stimulated with anti-CD3 (10 μg/mL,
from BD) and TGF-β (2 ng/mL, from R&D systems, as described
[4]), and CFSE-labeled enriched Treg cells were stimulated with
SEB at 2 ug/mL. After 5 days, cells were harvested and stained
for flow cytometric analysis, using the panel described above.
Statistical analysis
Statistical analyses were performed using Prism 4 software or
STATA 10 software. Normal distribution was assessed using the
D’Agostino & Pearson omnibus normality test. Where data were
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assessed to be normally distributed, parametric tests such as paired
t-test and regression analysis using the Peason’s correlation test
was performed; for nonnormally distributed data, the Mann–
Whitney test was used. When more than two groups were com-
pared, a one-way repeated ANOVA was performed, with Dunnett
post test adjusting for multiple comparisons.
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